Skip to main content

Research Repository

Advanced Search

Aggrecanase degradation of type III collagen is associated with clinical knee pain

Bay-Jensen, A.C.; Kjelgaard-Petersen, C.F.; Petersen, K.K.; Arendt-Nielsen, L.; Quasnichka, Helen; Mobasheri, A.; Karsdal, M.A.; Leeming, D.J.

Authors

A.C. Bay-Jensen

C.F. Kjelgaard-Petersen

K.K. Petersen

L. Arendt-Nielsen

Helen Quasnichka

A. Mobasheri

M.A. Karsdal

D.J. Leeming



Abstract

There is a lack of biochemical markers for non-invasive and objective assessment of symptomatic osteoarthritis (OA). Aggrecanase activity has been shown to be associated with joint deterioration and symptomatic disease through the degradation of extracellular matrix proteins, such as type III collagen. Our study aimed to identify and develop a novel biomarker by measuring an aggrecanase-mediated type III collagen neoepitope, and correlate levels of this biomarker with OA joint pain. Mass spectrometric analysis of purified type III collagen, degraded by the aggrecanase A Disintigrin and Metalloproteinase with Thrombospondin motif (ADAMTS), revealed a fragment generated by ADAMTS-1, -4 and -8. A monoclonal antibody was raised against the neoepitope of this fragment (COL3-ADAMTS) and a competitive ELISA was developed and tested; using serum samples from a cross-sectional cohort of patients with different degrees of knee OA (n = 261). The COL3/ADAMTS ELISA was technically robust and specific for the ADAMTS-1, -4 and -8 generated neoepitope. COL3/ADAMTS was released form cytokine stimulated synovial cultures, indicating a biologic link between the marker and synovium. In OA patients, serum COL3/ADAMTS was independently associated with pain scores (rho = −0.13–0.17, p < 0.05). This association was associated significantly with the presence of radiographic OA. Together, these data indicate that COL3/ADAMTS could be a marker of early osteoarthritis and the underlining pathology.

Citation

Bay-Jensen, A., Kjelgaard-Petersen, C., Petersen, K., Arendt-Nielsen, L., Quasnichka, H., Mobasheri, A., …Leeming, D. (2018). Aggrecanase degradation of type III collagen is associated with clinical knee pain. Clinical Biochemistry, 58, 37-43. https://doi.org/10.1016/j.clinbiochem.2018.04.022

Journal Article Type Article
Acceptance Date Apr 23, 2018
Online Publication Date Apr 25, 2018
Publication Date Aug 1, 2018
Deposit Date Jun 28, 2023
Journal Clinical Biochemistry
Print ISSN 0009-9120
Electronic ISSN 1873-2933
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 58
Pages 37-43
DOI https://doi.org/10.1016/j.clinbiochem.2018.04.022
Keywords Clinical Biochemistry; General Medicine
Public URL https://uwe-repository.worktribe.com/output/10339018
Publisher URL https://www.sciencedirect.com/science/article/pii/S0009912017307889?via%3Dihub
Additional Information This article is maintained by: Elsevier; Article Title: Aggrecanase degradation of type III collagen is associated with clinical knee pain; Journal Title: Clinical Biochemistry; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinbiochem.2018.04.022; Content Type: article; Copyright: © 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.